Introduction
Systemic vasculitis is an inflammatory disorder of blood vessels characterized by a perivascular cellular infiltrate around and fibrinoid necrosis within vessel walls. It may accompany a variety ofdiseases and may dominate clinical and pathological findings in polyarteritis (classical and microscopic), the Churg-Strauss syndrome, Wegener's granulomatosis, HenochSchonlein purpura, giant cell arteritis and Takayasu's disease -all 'primary' systemic vasculitides, the clinical and pathological features of which are described elsewhere (Cohen et al., 1980; Scott et al., 1982; McCluskey & Fienberg, 1983; Savage et al., 1985; Serra et al., 1984; Churg & Strauss, 1952; Chumbley et al., 1977; Pinching et al., 1983; Fauci et al., 1983; Counahan et al., 1977) . It is also associated with other well-defined systemic disorders including systemic lupus erythematosus, rheumatoid arthritis, mixed essential cryoglobulinaemia, subacute bacterial endocarditis and various types of malignancy (Fauci et al., 1978; Cupps & Fauci, 1982) . The pathological features of these 'primary' and 'secondary' vasculitides form a spectrum in which virtually all types and sizes of blood vessels are involved and no organ system is exempt.
Immunogenetic mechanisms such as passive deposition ofimmune complexes, direct antibody attack and cell mediated immunity, are generally thought to underlie the systemic necrotizing vasculitides, but detailed understanding remains poor. Aetiological factors are largely unknown, as are the factors determining organ distribution, size of vessel involved, presence or absence of granulomata and clinical expression of disease.
Immuno-pathogenetic mechanisms Immune complexes (a) Animal models ofimmune complex induced vasculitis
The animal models of serum sickness and of the Arthus reaction have been useful in elucidating mechanisms by which antibody may react with free antigens (to produce circulating immune complexes) or with tissue-associated antigens, to mediate tissue injury. However, other good models of vasculitis which reflect more accurately the human 'primary' systemic vasculitides, particularly those associated with granuloma formation, are lacking.
Serum sickness Clark & Kaplan (1937) first associated serum sickness with necrotizing vasculitis in man. Rich & Gregory (1943) , Germuth (1953) and Dixon et al. (1958) developed animal models in which rabbits were injected with horse serum or a large dose of a heterologous serum protein. From these studies which are well reviewed elsewhere (Cochrane & Koffler, 1973) it became evident that circulating and tissue bound immune complexes form at the time ofimmune elimination and that their appearance is associated with the development ofarterial, as well as glomerular, lesions. Later studies established that circulating complexes are normally removed by the reticuloendothelial system and other factors must pertain before deposition in vessel walls occurs (Cochrane & Koffler, 1973) . Such factors include vascular permeability, the size ofthe complexes, the affinity ofthe antibody, local hydrodynamic factors, the state of the reticuloendothelial system and the local characteristics of each tissue's endothelium and vessel wall architecture. Not only do multiple factors determine whether immune complexes will be deposited, but the subsequent pathogenesis of tissue injury triggered by their deposi-tion depends on several mediators including complement, neutrophil infiltration and possibly the coagulation and kallikrein-kinin system (Cochrane & Koffier, 1973) . Immune complexes certainly have the potential to interact with numerous humoral and cellular recognition systems since they can bind Clq, C4b and C3b complement components, fibronectin, rheumatoid factor and anti-idiotypic antibodies: these proteins can in turn interact with corresponding cell surface receptors (Nydegger, 1985) . Immune complexes may also impair the function of suppressor T cells and alter their expression of cell surface markers allowing the development of procoagulant activities which can initiate intravascular coagulation (Rothberger et al., 1977) .
The Arthus reaction The Arthus reaction is a localized acute immune complex vasculitis which develops in the skin of sensitized animals 4-10 hours after the local injection of antigen (Cochrane, 1965) . Histologically, the vessel walls show marked infiltration of red cells into the extravascular space. Early on, complexes can be identified by immunofluorescence but are removed by neutrophils within 24-48 hours of antigen injection (Cochrane et al., 1959) .
The Arthus reaction follows binding of preformed antibody to antigen, with subsequent activation of complement which initiates various immune adherence reactions, release of chemotactic factors, release ofanaphylatoxins (C3a and C5a) which trigger mast cell degranulation, and the formation of the membrane attack complex (Soter & Austen, 1980) . Infiltrating neutrophils bind to the complexes via their C3b receptors (CR1); phagocytosis and release of enzymes, inflammatory peptides and oxygen radicals is triggered by binding to antibody Fc determinants (Henson, 1982) . The generation of hydrogen peroxide and the hydroxyl radical by activated neutrophils may be particularly important in mediating tissue injury (Fligiel et al., 1984) ; iron may potentiate injury, and catalase or iron chelators may have a protective effect.
The acute serum sickness model and the Arthus reaction suggest that immune complexes form and are then deposited, or that antibody may react with fixed tissue antigen. However, these concepts are not exclusive. Firstly, other methods ofimmune aggregation can be envisaged such as 'planting' ofan antigen which has a particular affinity for a tissue by virtue of charge or other molecular interactions. Izui et al. (1976) reported that DNA may preferentially localize to the glomerular basement membrane. Secondly, a combination of processes may operate. Matsuo et al. (1985) demonstrated that antibody induces redistribution of surface antigen on rabbit oocytes which results in extrusion of antigen-antibody complexes into the adjacent zona pellucida where they become trapped. The evidence Vasculitis in man often develops in diseases with strong immunological associations, suggesting that the vasculitis too may be secondary to immunological damage. Evidence for immune complex mediated disease is derived from detection of circulating immune complexes using a variety of techniques, from demonstrations of their presence as cryoglobulins, from the development of hypocomplementaemia and from the demonstration ofimmune reactants in tissue by direct immunofluorescence. For example, circulating immune complexes (often accompanied by hypocomplementaemia) are detectable in most patients with vasculitis associated with hepatitis B infection (described in more detail below), systemic lupus erythematosus, rheumatoid arthritis, or bacterial endocarditis (Theofilopoulos & Dixon, 1979) . Cryoglobulins are associated with vasculitis in various infections, lymphoproliferative and collagen diseases (Franklin, 1980) ; patients with Type II mixed essential cryoglobulinaemia may also develop severe vasculitis (Gorevic et al., 1980) . Immunofluorescence studies have detected complement and immunoglobulin in vessel walls, as in the dermal vessels of patients with rheumatoid arthritis (Rapoport et al., 1980) , mixed essential cryoglobulinaemia (Gorevic et al., 1980) and systemic lupus erythematosus (Tan & Kunkel, 1966) . Further evidence for an association between immune complexes and vasculitis is derived from the observation that extra-articular disease in rheumatoid arthritis is associated with increased concentrations of circulating immune complexes (Zubler et al., 1976) . Several investigators have found a connection between the level of immune complexes and disease activity (Scott et al., 1982) and improvement has been reported following the removal of these and other factors by plasma exchange . Further, the strong association between immune complexes, and clinical symptoms was recently demonstrated in a prospective study in which heterologous antithymocyte globulin was injected in 11 patients, 8 of whom developed serum sickness (Lawley et al., 1984) .
Studies like these which have been reported by multiple centres, provide reasonable evidence that immune complexes are present in secondary vasculitides such as systemic lupus erythematosus, rheumatoid arthritis, cryoglobulinaemia and bacterial endocarditis. Yet despite their presence, it remains difficult to determine precisely the pathogenetic potential of immune complexes in systemic vasculitis since they are rarely detectable in 100% of these patients (Pussell et al., 1978) , they may be present in otherwise normal tissues (Baart de la Faille-Kuyper et al., 1973) or, conversely, undetectable in tissues with typical vasculitic lesions (Conn et al., 1972) , and disease activity may not correlate with measured levels group.bmj.com on May 30, 2017 -Published by http://pmj.bmj.com/ Downloaded from (Inman et al., 1980) . Problems in interpretation also arise since levels of immune complexes measured by different methods correlate poorly (Lambert et al., 1978) .
Understanding of immune complex mediated pathogenetic mechanisms gained from animal studies partly explains these inconsistencies: thus, immune complexes may circulate for a limited time (Dixon et al., 1958) , may be rapidly removed from tissues (Fye et al., 1977) and other factors such as complement and neutrophils may be required for tissue injury. In addition, measurement of fluid phase immune complexes may be misleading: the methods for immune complex detection are numerous and are mostly indirect, using antigen-nonspecific methods which depend on changes in either physicochemical (e.g. polyethylene glycol precipitation) or biological characteristics (e.g. Clq or rheumatoid factor binding assays) (Theofilopoulos & Dixon, 1979) . Furthermore, recent advances in the understanding of the normal handling of immune complexes suggest that in primates, immune complexes which have activated complement to become coated with C3b and C4b will bind to the C3b receptor (CR1) on erythrocytes. This erythrocyte-mediated carriage of immune complexes to the reticuloendothelial system has been demonstrated in baboons and monkeys (Cornacoff et al., 1983) . However, there is also in vitro evidence that erythrocyte-bound immune complexes are released by the action of factor I (Medof et al., 1982) , a physiological inhibitor of the complement system, which cleaves the C3b on the immune complex to C3dg. Since C3dg has no affinity for CR1, the immune complex is released from the erythrocyte (Figure 1 ). This process occurring in whole blood before sample separation (Y.C. Ng, unpublished) results in the detection of immune complexes that are altered in some biological properties including their phlogistic potential, and hence may be pathogenetically irrelevant. Furthermore, any single measurement of immune complexes will be affected by the percentage of complexes in the fluid phase, which in turn depends IC .C3b.
IC IC + C3b Factor * iC3b on factors such as the time elapsed before separation of the sample, changes in complement function, the nature of the immune complex (Horgan et al., 1984) and the density of CR1 on erythrocytes. The number of CR1 sites per erythrocyte is highly variable in the normal population (Ida et al., 1982) and is significantly reduced in systemic lupus erythematosus (Iida et al., 1982; Miyakawa et al., 1981; Walport et al., 1985) and rheumatoid arthritis (lida et al., 1982) . Evidence linking immune complexes with primary systemic vasculitides is even more tenuous than for the secondary vasculitides. Circulating or deposited immune complexes, cryoglobulinaemia or hypocomplementaemia are the exception rather than the rule. For example, a recent study examined the incidence of these abnormalities in 43 patients with polyarteritis or Wegener's granulomatosis (Ronco et al., 1983) . Cryoglobulins were detectable in about 20% and hypocomplementaemia was not found. Immune complexes were detectable in less than one third ofpatients using a Raji cell assay but in most patients using a Clq binding assay. Deposits of immunoglobulin or complement in renal arterial walls and glomeruli were scant. These studies suggest that immune complexes may not be the primary pathogenetic mechanism inducing these types of vasculitis.
Host factors which affect deposition of immune complexes andpathogenesis oftissue injury It is likely that the potential pathogenicity of immune complexes will partly depend on the physicochemical and biological properties of the antigen, the antibody and the complex -factors which have been discussed in detail in other reviews (Nydegger & Lambert, 1980) . Briefly, the molecular size of the antigen, the number of antigenic sites recognized by antibody, the affinity and concentration of antibody, and the ratio of antigen to antibody concentrations, influence the characteristics of the immune complex generated. Host factors, such as the state of the reticuloendothelial system, abnormalities of the complement system and local tissue factors (ultrastructure, cellular receptors etc.) Frank et al., 1979; Williams et al., 1979; Hamburger et al., 1982 ). An association between immune clearance defects and HLA-B8 DR3 (Lawley et al., 1981) or HLA-DR2 (Kimberley et al., 1983) has also been reported. It has been suggested that these associations could arise from a direct blocking effect of circulating immune complexes on reticuloendothelial Fc receptor function or, alternatively, that some patients may have a genetically determined Fc receptor defect that predisposes to immune dysregulation (Lawley et al., 1981; Kimberley et al., 1983) . In support of an acquired reticuloendothelial system dysfunction is the demonstration of reversibility with plasma exchange . However, others have failed to demonstrate defective clearance of IgG coated or heat damaged erythrocytes in these diseases (Elkon et al., 1980; Kabbash et al., 1982; Swaak et al., 1984) , indeed the value of IgG coated erythrocyte clearance as a measure of reticuloendothelial Fc receptor function has been questioned (Frank et al., 1983) and the mechanisms of clearance of heat damaged erythrocytes are even less clear. Thus, at the present time, data on reticuloendothelial function in patients with vasculitis is conflicting and the situation is far from clear.
Deficiencies of the complement system are associated with an increased incidence of immune complex mediated disease. This association is strongest in patients with inherited defects of the classical pathway, particularly Cl subcomponents or C4 (Schifferli & Peters, 1983) , but the reasons for this association are not entirely clear. Since C2, C4 and Factor B are encoded within the MHC, it has been suggested that the association results from linkage disequilibrium with other disease susceptibility genes. However, genes for Clr, Cls, Clq and C3 are not linked to HLA, suggesting that it is loss ofcomplement function that is important: the classical complement pathway is involved in the inhibition of precipitation of antigen-antibody complexes (Schifferli et al., 1982) whereas solubilization of antigen-antibody precipitates is mainly an alternative pathway function (Czop & Nussenzweig, 1976 (Ryan et al., 1981; Cines et al., 1982) , thereby promoting active binding of immune complexes to these cells. Renal epithelial cells have been found to express CR1 (Fearon, 1984) and both CR1 and Fc receptors have been detected in human choroid plexus (Peress et al., 1981; Braathen et al., 1979) , although the function of receptors in these sites is unknown.
(c) Antigens responsiblefor immune complex vasculitis Identification of the nature of the antigens in immune complexes is potentially of value in determining the precise disease aetiology and in allowing the administration of accurate therapy (Nydegger, 1985) .
Animals Spontaneous immune-complex disease occurs in both animals and man as a result of both foreign and autologous antigens. In animals, vasculitic disease may result from viral infection; for example there is strong evidence for the participation of viral antigen-host antibody complexes in the pathogenesis ofaleutian disease ofmink (Henson & Gorham, 1973) . Animals, particularly NZB/NZW Fl hybrid mice, may develop autoimmune disease with DNA-anti-DNA complexes (Cochrane & Koffier, 1973) .
Vasculitis and specific infection in man In man, the best known example of a foreign antigen provoking immune complex mediated vasculitis is that associated with hepatitis B (Gocke et al., 1970; Trepo et al., 1970 Vasculitis in man has been associated with a variety of other viral infections including herpes simplex (Phinney et al., 1982) , cytomegalovirus infection (Doherty & Bradfield, 1981) and more recently, human serum parvovirus (Li Loong et al., 1986 ).
Bacterial antigens from-several agents including streptococci (Ingelfinger et al., 1977) , staphylococci (Boulton-Jones et al., 1974) and meningococci (Davis et al., 1976) have also been implicated. Both antigen and specific antibody have been found in lesions (Nydegger, 1985) . In such infections, the immune response of the host may play a major role in determining the pathological manifestations: in subacute bacterial endocarditis complexes were mainly found in patients with disease of longer duration and with marked systemic manifestations (Bayer et al., 1977) .
In Kawasaki disease (mucocutaneous lymph node syndrome) there is indirect evidence that an as yet unidentified infective organism may provoke the vasculitic illness; a feverish phase is followed in the third week by thrombocytosis, increased platelet aggregation, serotonin release and circulating immune complexes. The latter may be responsible for the platelet aggregation (Levin et al., 1985) . There are many similarities between the manifestations of this disease and serum sickness.
Drugs and vasculitis Several drugs have been associated with the development of vasculitis, including iodine (Rich & Gregory, 1943) , sulphonamides (Rose & Spender, 1957) , penicillin (Waugh, 1952) , and, more recently alclofenac (Billings et al., 1974) . Vasculitis has also followed vaccination with inactivated influenza virus (Blumberg et al., 1980) and desensitizing injections for atopic respiratory disease (Phanuphak & Kohler, 1980 ). However, a major problem with these observations is determining whether a drug was given for early manifestations of the vasculitis or whether it played a truly causative role; similarly, a cause and effect relationship between vaccination, desensitizing injections and vasculitis has not been proven.
Neoplasia and vasculitis Clinical vasculitis syndromes have been associated with neoplasia, including hairy cell leukaemia (Elkon et al., 1979; Goedert et al., 1981) , chronic leukaemia (McCombs, 1965) , Hodgkin's disease (Sams et al., 1968) , multiple myeloma (Williams et al., 1985) and the 'pre-leukaemic' stage of monocyte leukaemia (Leung et al., 1986) (Nydegger, 1985; Theofilopoulos & Dixon, 1979) . In addition, the participation of idiotype -anti-idiotype complexes in immune complex mediated disease opens up new possibilities (Kunkel, 1984 
Direct antibody attack
There is evidence that cell specific autoantibodies may group.bmj.com on May 30, 2017 -Published by http://pmj.bmj.com/ Downloaded from contribute to pathogenesis of tissue injury in some vasculitic diseases. Such mechanisms may also be considered as 'in situ' complex formation with antibody binding to autologous antigens, but they will be discussed separately from the previous section, since they raise some interesting points.
In SLE, IgG anti-endothelial antibodies have been demonstrated (Cines et al., 1984) which can fix C3 and release PGI2 from endothelial cells with subsequent adherence of platelets. It has been suggested, but not proven, that D/DR antigens are the target antigen since both B cells and monocytes can adsorb out the activity. Such surface-bound IgG could potentially attract leucocytes to the vessel wall allowing a variety of mediators of tissue injury to participate.
Autoantibodies have also been found in Wegener's granulomatosis (van der Woude et al., 1985; Jones & Lockwood, unpublished observations) which appear to be directed towards extranuclear components of granulocytes and monocytes. The significance of such antibodies for the pathogenesis of the small vessel vasculitis and the granulomatous reaction found in Wegener's, is unclear at the present time. However, it is interesting that intravascular lysis of leucocytes has been described as an early event in the process oftissue injury (Donald et al., 1976) ; the lysis was followed by platelet aggregation and fibrin deposition in vessels with intact endothelial cells.
The detection of antibodies to granulocytes and monocytes is intriguing in view of the demonstration, using monoclonal antibodies, of shared antigens between blood monocytes, granulocytes, tissue macrophages and some types ofendothelial cells (Hogg et al., 1984; Knowles et al., 1984) . Endothelial cells and macrophages were found to share unique non-HLA-DR antigens not expressed on B lymphocytes or other tissues which may have important implications for lymphocyte-endothelial cell interaction (see below). In other studies, the monoclonal antibody OKM5, showed that antigenically distinct types ofendothelial cell were present within one organ, namely the kidney; OKM5 was reactive with renal medullary, but not cortical, small vessel endothelial cells, and was unreactive with glomerular capillary endothelial cells (Knowles et al., 1984) . Such observations suggest tissue specificity of the vasculitic process may partly depend on the surface molecules which endothelial cells carry, and that these may vary both between and within organs.
Cellular mechanisms
The role of particular cell types namely endothelial cells, vascular smooth muscle cells, eosinophils and lymphocytes will be discussed. It is likely that macrophages are also involved, particularly in the granulomatous vasculitic disorders, but information on the nature of their participation is scant.
(a) Cellular mechanisms in Iymphocyte-predominant vasculitis Some types ofvasculitis are characterized by a perivascular lymphocyte and macrophage infiltrate (Soter & Austen, 1980) with few, if any, accompanying neutrophils which are so characteristic of the immune complex-induced serum sickness of vasculitis. The lymphocyte-predominant type of vasculitis is particularly associated with cutaneous vasculitides (Soter & Austen, 1980) but may be observed in human systemic vasculitis (McCluskey & Fienberg, 1983) and it has been suggested by some investigators that nonimmune complex mediated mechanisms of injury may be involved (Moyer & Reinisch, 1984) . Thus the role of endothelial and smooth muscle cells in promoting the lymphocyte influx is under investigation.
Endothelial cells have the potential to play an active role in the induction of vasculitis since not only may they share surface determinants with various haemopoietic cell lines (see above) (Ryan et al., 1981; Hirschberg et al., 1979) , but they are also capable of behaving as antigen presenting cells (Hirschberg et al., 1980) . In one study BALB/c splenic lymphocytes were activated by co-culturing in vitro and in vivo with an endothelial mouse cell line (ME-2 cells); the lymphocytes underwent proliferation and were then injected intravenously into syngeneic mice who developed vasculitis in the lungs, brain and other organs. It was suggested that endothelial cell antigens (cross-reactive between ME-2 cells and BALB/c endothelial cells) were able to sensitize the splenic lymphocytes which, following injection into the host, were able to by-pass suppressor mechanisms and recruit host cells to amplify vascular injury (Hart et al., 1983) .
It has also been proposed that vascular smooth muscle cells (VSMC) may play an active role in recruiting lymphocytes (Moyer & Reinisch, 1984) . In vitro studies of VSMCs and splenocytes from the MRL/lpr mouse, which is particularly prone to develop arteritis, showed that the VSMCs were able to stimulate a mononuclear inflammatory cell phlogistic response, culminating in VSMC autodestruction. The VSMCs from these autoimmune mice spontaneously express Ia (which could promote T-cell sensitization to 'self' antigens) and released an interleukin-l-like factor (which could encourage a lymphoid influx into the vascular site).
Preliminary studies in humans suggest lymphocytes may play a role in certain types of vasculitis. Thus, increased lymphocyte mediated cytotoxicity to "'indium-labelled human endothelial cells was observed in 7 patients with giant cell arteritis and Takayasu's disease, whilst serum mediated cytotoxicity (e.g. mediated by oxidized lipoproteins) was increased in 7 patients with systemic necrotizing vasculitis (Scott et al., 1984) .
(b) The role of eosinophils in vasculitis The Churg-Strauss syndrome is characterized by hypereosinophilia and a granulomatous vasculitis (Churg & Strauss, 1952) . Activated and degranulated eosinophils have been seen migrating towards the granulomatous lesions which have been found to contain large amounts of eosinophil cationic protein and eosinophil protein-X (which are toxic to many cells and tissues) (Tai et al., 1984) . Raised IgE levels are found in some patients with the syndrome which may trigger eosinophils to take part in cytotoxic reactions (Conn et al., 1976) via their recently demonstrated IgE receptors (Capron et al., 1981) . Thus it is possible that eosinophils play a central role in the pathogenesis of this granulomatous vasculitis and the severity of the disease may be partly related to the extent of eosinophil degranulation in tissues.
Wegener's granulomatosis is also a granulomatous vasculitis in which elevated IgE levels have been reported (Conn et al., 1976 ) but a role for eosinophils, if any, in this disease has not yet been substantiated.
Non-immuno-pathogenetic mechanisms.
Non-immunological mechanisms may cause vasculitis, including necrotizing arteritis. Encephalomyocarditis of mice is probably caused by direct infection of vascular elements by virus, and viral particles have been demonstrated in and around the blood vessels (Sergent, 1980) . Turkeys injected with mycoplasma gallisepticum develop cerebral arteritis which seems to be mediated by mycoplasma toxins (Thomas et al., 1966) . Necrotizing arteritis may occur in rats with spontaneous hypertension and the vascular lesions may contain immunoglobulin (Ohta et al., 1959) .
Conclusions
The aetiology and pathogenesis ofvasculitis and of the primary systemic vasculitides in particular, remain largely speculative -progress has been hampered by the considerable clinical and pathological overlap between many of the syndromes. The animal models of serum sickness and the Arthus reaction have been helpful in understanding certain aspects of the pathogenesis of these disorders but many gaps and inconsistencies remain. It is likely that both humoral and cellular mechanisms mediate tissue injury but specificity must develop at some point to allow a patient with say, polyarteritis nodosa to be differentiated from one with Wegener's granulomatosis. DIXON 
